- Homozygous and heterozygous penetrance of a missense CASQ2 variant in a South Asian family
- Introduction of a single carboxylic acid converts the cyclic oligomeric depsipeptide ent-verticilide from a ryanodine receptor 2 (RyR2) inhibitor to RyR2 activator
- Catecholaminergic polymorphic ventricular tachycardia: A narrative review of recent advances in genetics, mechanisms, diagnosis, and treatment
- Signature ECG: Exercise induced syncope
- Pediatric and Familial Genetic Arrhythmia Syndromes: Evaluation of Bidirectional Ventricular Tachycardia-Differential Diagnosis
- Comparative Investigation of Cx3cr1-Expressing Cardiac Macrophages in Atrioventricular Nodes of Wild-Type and Catecholaminergic Polymorphic Ventricular Tachycardia Mouse Model
- RYR2 Exon 3 Deletion as a Cause of Convergent Catecholaminergic Polymorphic Ventricular Tachycardia and Cardiomyopathy
- Neurocognitive Delay in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
- A Homozygous Mutation (c.241G > A, p.A81T) in the Calsequestrin-2 Causes Eye Defects in Zebrafish
- Cardiac Channelopathies in the Pediatric Patient: The Ryanodine Receptor Related Inherited Cardiac Syndromes
- A ryanodine receptor 2 gene variant associated with left ventricular non-compaction, cardiac conduction disease, ventricular arrhythmias, and sudden cardiac death
- Increased Intermembrane Space [Ca(2+)] Drives Mitochondrial Structural Damage in CPVT
- Increased Intermembrane Space [Ca2+] Drives Mitochondrial Structural Damage in CPVT
- Direct Therapeutic Modulation of RYR2 Activity by CMYA5
- Comparative evaluation of two behavior guidance techniques in reducing pain perception and anxiety during local anesthesia administration in children: a randomized clinical trial
- A positive allosteric modulator of the beta1AR with antagonist activity for catecholaminergic polymorphic ventricular tachycardia
- A positive allosteric modulator of the β1AR with antagonist activity for catecholaminergic polymorphic ventricular tachycardia
- Portal cavernoma cholangiopathy: A systematic review of current understanding, clinical significance, and management
- Intellectual and Neurodevelopmental Delays in Pediatric Catecholaminergic Polymorphic Ventricular Tachycardia: Distinct Characteristics and a More Malignant Neurocardiac Phenotype
- Reply to the comment on "Genetic and clinical characteristics of catecholaminergic polymorphic ventricular tachycardia in a Taiwanese nationwide cohort"
- Seizure-Syncope: Clinical implications from two Chinese CPVT children with two novel RYR2 variants
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence
- CPVT1 point mutations in RyR2 S5 and S6 segments and their Ca2+ signaling consequence